Implicit Bioscience
About:
Implicit Bioscience operates as a clinical-stage drug development company.
Website: http://www.implicitbioscience.com/
Top Investors: Defense Threat Reduction Agency (DTRA)
Description:
Implicit Bioscience operates as a clinical-stage drug development company. It applies breakthrough discoveries in immunology to make transformational changes to the way they manage inflammatory and infectious diseases. Implicit Bioscience was founded in 2004 and is based in Seattle, Washington.
Total Funding Amount:
$17M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Seattle, Washington, United States
Founded Date:
2004-01-01
Founders:
Garry Redlich
Number of Employees:
11-50
Last Funding Date:
2020-08-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai